SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells agreed all-stock acquisition of Lumentum is driving the discussion, with many traders blaming the steep selloff on dilution, the deals scale and its long path to closing. Others see the combination of Marvells connectivity chips and Lumentums optical technology as a strategic bet on AI data centers, but its long-term payoff remains uncertain.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is under pressure amid a semiconductor selloff following Intels disappointing results, with traders debating whether Intels weakness signals broader chip-demand concerns or is company-specific. Attention is focused on AMDs upcoming earnings and guidance: bears fear a weak outlook and high valuation, while bulls view the selloff as overdone and expect AMD to fare better than Intel.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples fiscal Q4 report and first earnings call under CEO John Ternus are the focus, with traders weighing holiday-quarter guidance, iPhone demand and rising memory costs against a high valuation. Views are sharply divided: many expect a selloff, while others point to Apples relative resilience and cash generation, and see its results as important for broader tech sentiment.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp S&P pullback and volatile swings are driving discussion, with traders focused on weakness in technology and AI stocks, midterm-election uncertainty, and Apple and Palantir earnings as potential catalysts. Bears warn of a deeper correction, while bulls view the selloff as a possible shakeout and look for a rebound.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, but LITE has sold off sharply as the fixed exchange ratio ties its value to MRVLs share price and the deal is not expected to close until 2028. Traders criticize the dilution, long wait and uncertain deal value, while others argue the combination could benefit from growing AI-optics demand and view the decline as a buying opportunity.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention amid a tech- and AI-led selloff, with traders questioning whether heavy AI investment can deliver enough returns and pointing to weakness in major technology stocks. Bearish calls dominate, though some traders see oversold conditions as a buying opportunity; election uncertainty and upcoming earnings add to the debate.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

Semiconductor stocks are under pressure amid an AI-trade selloff, with traders focused on concerns about AI spending, debt and whether infrastructure investments will deliver sufficient returns, alongside weak Intel guidance. The community is split between seeing a bubble or cyclical peak and buying the dip on the view that chip and data-center demand remains durable.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs Q3 earnings report is the main focus, with traders watching whether U.S. commercial AI growth and forward guidance can meet high expectations. The community is split between hopes for a strong beat and renewed gains, and concerns that the premium valuation and broader AI-stock weakness could trigger a sell-the-news reaction.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

A reported Usona FDA application for psilocybin in major depressive disorder has sharpened concerns that the rival could challenge Compasss lead as COMP360 approaches its own NDA completion, contributing to a steep selloff. Traders debate how serious the competitive threat isciting the different patient indication and Usonas nonprofit structurewhile looking to Compass management for clarity on its filing timeline.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas is drawing attention after its Phase 3 REGAL trial reached the prespecified 80-event threshold, triggering final analysis ahead of the GPS topline results. Traders are debating a steep selloff: some attribute it to profit-taking and short pressure, while others see it as a warning about the trial outcome, which remains unconfirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The move appears tied to optimism around federal cannabis rescheduling, with traders focusing on the pending DEA administrative-law process and the possibility that Schedule III status would end Section 280E tax treatment. Election-related legalization hopes and heavy call activity also surfaced, but remain speculative.

MSOS, TRLV Slide After Hours As DEA Judge Pauses Cannabis Rescheduling Case  

Equity

DEA Chief Judge Derek Julius paused the cannabis rescheduling case on Tuesday afternoon.


This US Cannabis Giant Is Launching Its First Premium Offering In Germany – Why It Matters?

Tilray’s ARX brand will be launched at the world's largest cannabis expo and festival, Mary Jane Berlin 2026, which kicks off in two days. 

MSOS Hits 2026 High: Which Cannabis Stock Could Light Up Portfolios Ahead Of DEA Hearing?

The cannabis ETF has surged 104% over the past year, outperforming both the North American Marijuana Index and the S&P 500.

TLRY Stock Back Into The Limelight – A Look At The Key Developments That Sparked Investor Optimism

Tilray stock was in focus after a recent government effort to reclassify Hemp and the upcoming DEA hearing about marijuana.

US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High? 

 Medical marijuana's US reclassification revives cannabis ETFs like WEED, with tax relief and reform hopes fueling sharp gains across the sector.

4 Best-Performing ETF Areas of Last Week

Cannabis, semis, crude & hydrogen ETFs led last week as AI momentum, policy boost and Middle East tensions shaped market trends.

Tilray Stock Eyes Breakout Week: Trump’s Cannabis Order Opens Door To US Cancer Market Entry

Trump has also called on Congress to preserve access to full-spectrum CBD products and expand research.

TLRY, CGC, ACB, MSOS Pare Early Gains After Marijuana Reclassification: Retail Says ‘Weed Industry Is Reborn’

The U.S. Department of Justice formally moved to reclassify state-licensed medical marijuana as a less dangerous drug, four months after President Donald Trump signed an executive order.

AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling

AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling PR Newswire BETHESDA, Md., April 23...

TLRY, CGC, IGC Stocks Light Up On Trump Pot Reclassification Hopes This Week  

Axios reported on Wednesday, citing an administration official, that the Trump administration is slated to reclassify marijuana as soon as Wednesday. 


Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Rescheduling changes where marijuana sits under the federal Controlled Substances Act instead of legalizing it.</li><li>In April, the Justice Department moved two categories of marijuana to Schedule III: FDA-approved products that contain marijuana, and marijuana grown or sold under a qualifying state medical license.</li><li>The stay does not reject rescheduling or cancel the earlier medical-marijuana rule.</li></ul>The AdvisorShares Pure US Cannabis ETF (<a class="mention" data-mention="$MSOS" data-symbol-id="MSOS" href="https://stocktwits.com/symbol/MSOS" target="_blank">MSOS</a>) fell as much as about 8% after hours Tuesday after a federal judge paused the leftover case on reclassifying marijuana, including adult-use product, to Schedule III from Schedule I.Trulieve Cannabis (TRLV), one of the ETF’s largest holdings, finished regular trading at $12.41, up 0.6%, then traded as low as about $11, a drop of roughly 9% in extended hours.<h2 class="st-heading-2">What The Judge Ordered</h2>DEA Chief Judge Derek Julius paused the case on Tuesday afternoon. The public hearing ended in mid-July. He had been expected to send a recommendation to the DEA administrator next. That step is now on hold.On Sept. 28, three hearing participants who oppose broader rescheduling — DUID Victim Voices, Dr. Kenneth Finn, and the National Drug and Alcohol Screening Association — asked him to add a Sept. 23 Government Accountability Office report on drug-scheduling procedures to the record and to allow extra briefing. Julius said a stay was warranted while he decides whether to reopen the record. The government must respond by Oct. 13. Other parties may file replies by the same date.<h2 class="st-heading-2">What Rescheduling Means</h2>Rescheduling changes where marijuana sits under the federal Controlled Substances Act. It is not the same as legalizing it. Schedule I is the tightest box: high abuse potential and no accepted medical use. Marijuana has been listed there since 1970. Schedule III is looser. It covers drugs with accepted medical use and lower abuse potential than Schedule I or II. Moving a drug down the list does not take it off the list.In April, the Justice Department moved two categories of marijuana to Schedule III: FDA-approved products that contain marijuana, and marijuana grown or sold under a qualifying state medical license. The paused case is about the rest of the plant, including adult-use product.The stay does not reject rescheduling or cancel the earlier medical-marijuana rule. It delays a decision investors had treated as a near-term catalyst.<h2 class="st-heading-2">How Did <a class="mention" data-mention="$MSOS" data-symbol-id="MSOS" href="https://stocktwits.com/symbol/MSOS" target="_blank">MSOS</a>, TRLV Retail Traders React?</h2>On Stocktwits, retail sentiment around TRLV and <a class="mention" data-mention="$MSOS" data-symbol-id="MSOS" href="https://stocktwits.com/symbol/MSOS" target="_blank">MSOS</a> stayed within the bullish territory at he time of writing.“Broader rescheduling is less likely now,” a Stocktwits user wrote.<stembedurl>https://stocktwits.com/Alexsolstice/message/665384525</stembedurl>Another user dismissed the selloff, saying a rescheduling will come in the future.<stembedurl>https://stocktwits.com/Lboog27/message/665380883</stembedurl>TRLV has gained about 43% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/qure-stock-clocks-worst-day-in-over-10-months-four-year-huntington-s-data-spooks-investors-despite-stronger-three-year-filing-data/cZMZh6KRBWi">QURE Stock Clocks Worst Day In Over 10 Months: Four-Year Huntington’s Data Spooks Investors Despite Stronger Three-Year Filing Data</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Close-up of fresh cannabis plant on sunny day. Natural pattern is on green leaf. Organic hemp is growing at farm.

DEA Chief Judge Derek Julius paused the cannabis rescheduling case on Tuesday afternoon.

MSOS, TRLV Slide After Hours As DEA Judge Pauses Cannabis Rescheduling Case

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp

Up more than 3%

Flat to up 3%

Flat to down 3%

Down more than 3%

What’s your expected total return for the S&amp;P 500 ($SPY) in November?

Stocktwits

What’s your expected total return for the S&P 500 (

Current Price	$4.20
Prev Close	$3.94
Open	$4.02
Dividend Yield	N/A
50-Day Moving Average	$4.62
Beta	N/A
Avg. Volume	5.43M
PE Ratio	N/A

52-Week High	$7.25
52-Week Low	$2.96
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

MSOS Fundamentals